This independent HPLC lab test confirms Survodutide 11.36mg from NEXAPH at 99.438% purity. The analysis was conducted by Janoshik Labs on September 17, 2025.
Survodutide is a dual GLP-1/GCN receptor agonist researched for its role in metabolic regulation and weight management. A purity level of 99.438% indicates minimal contamination and high-grade synthesis.
The full certificate of analysis is available for verification at www.janoshik.com with the unique key EIN14I938FV6.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.